During the past decade, Mid Ohio Cardiology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mid Ohio Cardiology" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Mid Ohio Cardiology" are "Arrhythmias" (1 trials), "Cardiomyopathy" (1 trials), "Congestive Heart Failure" (1 trials), "Femoral Artery Occlusion" (1 trials) and "Femoral Artery Stenosis" (1 trials). Many other conditions were trialed in "Mid Ohio Cardiology" in a lesser frequency.

Most popular intervention types in "Mid Ohio Cardiology" are "Device" (3 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amiodarone, flecainide, propafenone, quinidine, dofetilide, sotalol, cibenzoline, beta blocking and calcium channel blocking agents and antiarrhythmic drugs" (1 trials), "Lutonix Drug Coated Balloon" (1 trials), "Moxy Drug Coated Balloon" (1 trials), "Radiofrequency ablation, antiarrhythmic drugs" (1 trials) and "Standard Uncoated Angioplasty Balloon" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mid Ohio Cardiology" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Mid Ohio Cardiology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Mid Ohio Cardiology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mid Ohio Cardiology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".